Recurrent uterine cancer after surgery: magnetic resonance imaging patterns and their changes after concomitant chemoradiation.
OBJECTIVE
Our primary objective was to describe the magnetic resonance (MR) imaging patterns of recurrent uterine cancer after surgery and their changes following concurrent chemoradiation. The secondary objective was to identify MR imaging predictors of outcome.


METHODS
Twenty-two consecutive women with biopsy-proven recurrent uterine cancer after surgery (cervix 13 patients, endometrium nine patients) were enrolled in this prospective study. Inclusion criteria were MR imaging at diagnosis and during follow-up and eligibility for concurrent chemoradiation. MR images were assessed for signal intensity of the pelvic relapse on T2-weighted images, site of relapse and infiltration of adjacent organs. Pre- and posttreatment MR images were compared on the basis of the same criteria. The 3D volume of relapses after treatment was calculated, and tumour response to treatment was evaluated as complete, partial, no change or disease progression.


RESULTS
Recurrences appeared hyperintense on T2-weighted images in 22/22 (100%) patients. Pelvic relapse site was vagina in 5/22 (23%), vaginal vault in 9/22 (41%), vaginal vault with extension to the pelvic wall in 5/22 (23%) and pelvic wall in 3/22 (13%). Infiltration of adjacent organs was detected in 9/22 (41%) patients. The mean volume of recurrences on pretreatment MR images was 38.83 cm(3). On posttreatment MR images, relapses appeared hypointense in 19/22 (86%) patients and hyperintense in 3/22 (14%). The mean volume of recurrences on posttreatment MR images was 18.01 cm(3). Complete response was seen in 11/22 (50%) patients, partial response in 8/22 (36%) and no change in 3/22 (14%).


CONCLUSIONS
MR imaging can provide an evaluation of all parameters necessary for planning treatment and assessing response to treatment.
Manfredi
R
R
Department of Radiology, University of Verona, P.le L.A. Scuro 10, 37134, Verona, Italy, rmanfredi@univr.it.
Baltieri
S
S
Tognolini
A
A
Graziani
R
R
Smaniotto
D
D
Cellini
N
N
Bonomo
L
L
D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D014594:Uterine Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*
Gynecol Oncol. 1990 Sep;38(3):446-51
2227560
Semin Oncol. 1995 Oct;22(5 Suppl 12):67-75
7481864
Cancer. 1993 Feb 15;71(4 Suppl):1422-37
8431876
Obstet Gynecol. 1987 Mar;69(3 Pt 1):382-5
3822285
Radiology. 1998 Dec;209(3):819-24
9844681
Dis Colon Rectum. 1993 Jul;36(7):709-11
8348857
Gynecol Oncol. 1984 Jan;17(1):85-103
6693055
Clin Radiol. 2007 Jan;62(1):28-34; discussion 35-6
17145260
Gynecol Oncol. 1988 Jul;30(3):381-7
3391421
Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S241-7
17826824
Radiology. 1988 Feb;166(2):333-40
3422025
Int J Radiat Oncol Biol Phys. 1998 Apr 1;41(1):7-11
9588911
Gynecol Oncol. 1989 Sep;34(3):395-401
2767531
Obstet Gynecol. 1974 Aug;44(2):265-72
4417035
Cancer. 1994 Aug 15;74(4):1303-8
8055452
Cancer. 1981 Jan 1;47(1):207-14
7459811
Int J Radiat Oncol Biol Phys. 1985 Jun;11(6):1103-9
3997592
Obstet Gynecol. 1982 Apr;59(4):422-7
7078892
Tumori. 2005 Jul-Aug;91(4):295-301
16277092
Gynecol Oncol. 1998 Aug;70(2):241-6
9740698
Gynecol Oncol. 2000 Apr;77(1):66-72
10739692
Clin Radiol. 1994 Jul;49(7):443-52
8088035
Gynecol Oncol. 2000 Sep;78(3 Pt 1):324-8
10985888
Int J Gynaecol Obstet. 2000 Aug;70(2):209-62
11041682